LAX.SH
SUMITOMO CHEM INDIA LTD·AGROCHEMICAL 21.89PESTICIDES 28.50·Fertilizers & Agrochemicals Companies
Price
370.5
-3.55%52W Range
Market Cap
₹18,493.35 Cr
Traded: ₹16.79 Cr (0.09%) 0.0x
Free Float: ₹2,339.41 Cr (0.72% of FF traded)
Volume · 60D trend
4.49 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +4.0% | -3.0% | -- | -4.0% | Decelerating |
| ROE | -- | +19.0% | +16.0% | -- | -- | Decelerating |
| Return | -- | +4.0% | +9.0% | -9.0% | -- | Stable |
| Profit | -- | +8.0% | +2.0% | -- | +3.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,063 | 684 | 568 | 930 | 1,057 | 679 | 642 | 988 | 839 | 674 | 542 | 903 | 724 | 652 | 753 |
| Expenses | 830 | 550 | 468 | 712 | 838 | 560 | 536 | 743 | 678 | 534 | 476 | 716 | 644 | 571 | 633 |
| Operating Profit | 233 | 134 | 99 | 218 | 219 | 120 | 106 | 245 | 161 | 140 | 66 | 188 | 81 | 81 | 120 |
| Other Income | 74 | 32 | 21 | 39 | 39 | 32 | 31 | 31 | 26 | 27 | 27 | 25 | 18 | 16 | 13 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 17 | 17 | 17 | 17 | 16 | 16 | 19 | 16 | 15 | 17 | 16 | 16 | 14 | 14 | 11 |
| Profit Before Tax | 288 | 148 | 102 | 238 | 241 | 133 | 117 | 260 | 171 | 149 | 75 | 196 | 83 | 82 | 121 |
| Tax % | 26.0% | 25.0% | 25.0% | 25.0% | 26.0% | 25.0% | 25.0% | 26.0% | 26.0% | 26.0% | 27.0% | 27.0% | 26.0% | 12.0% | 25.0% |
| Net Profit | 215 | 111 | 76 | 178 | 178 | 100 | 87 | 193 | 127 | 110 | 55 | 143 | 62 | 72 | 90 |
| Exceptional Items | 27 | 0 | -16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 4.3 | 2.2 | 1.5 | 3.6 | 3.6 | 2.0 | 1.7 | 3.9 | 2.5 | 2.2 | 1.1 | 2.9 | 1.2 | 1.4 | 1.8 |
| Sales Growth (YoY) | 0.6% | 0.7% | -11.5% | -5.9% | 26.0% | 0.7% | 18.4% | 9.4% | 15.9% | 3.4% | -28.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 55.4% | 20.4% | -38.9% | -12.0% | 55.7% | 5.8% | -35.0% | 17.8% | 24.5% | 24.4% | -40.0% | 24.7% | 11.0% | -13.4% | -- |
| OP Growth (YoY) | 6.4% | 11.7% | -6.6% | -11.0% | 36.0% | -14.3% | 60.6% | 30.3% | 98.8% | 72.8% | -45.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 73.9% | 35.4% | -54.6% | -0.5% | 82.5% | 13.2% | -56.7% | 52.2% | 15.0% | 112.1% | -64.9% | 132.1% | 0.0% | -32.5% | -- |
| Profit Growth (YoY) | 9.0% | 12.0% | 1.0% | -8.0% | 41.0% | -9.0% | 59.0% | 34.0% | 105.0% | 52.0% | -40.0% | -29.0% | -55.0% | -3.0% | 2.0% |
| EPS Growth (YoY) | 20.4% | 11.5% | -12.6% | -7.5% | 40.5% | -9.1% | 58.2% | 34.1% | 104.8% | 51.7% | -39.2% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 92.8% | 46.7% | -57.3% | -0.3% | 78.5% | 14.9% | -54.8% | 51.6% | 15.4% | 100.0% | -61.7% | 131.4% | -14.5% | -19.9% | -- |
| OP Margin | 21.9% | 19.6% | 17.4% | 23.4% | 20.7% | 17.7% | 16.5% | 24.8% | 19.2% | 20.8% | 12.2% | 20.8% | 11.2% | 12.4% | 15.9% |
| Net Margin | 20.2% | 16.2% | 13.4% | 19.1% | 16.8% | 14.7% | 13.6% | 19.5% | 15.1% | 16.3% | 10.2% | 15.8% | 8.6% | 11.0% | 11.9% |
| Material Cost % | 61.0% | 58.0% | 53.0% | 57.0% | 62.0% | 60.0% | 58.0% | 57.0% | 61.0% | 58.0% | 60.0% | 62.0% | 69.0% | 69.0% | 65.0% |
| Employee Cost % | 7.0% | 10.0% | 12.0% | 7.0% | 7.0% | 10.0% | 11.0% | 7.0% | 8.0% | 9.0% | 10.0% | 7.0% | 8.0% | 8.0% | 7.0% |
| P/S | 5.70 | 8.03 | 7.55 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 31.91 | 48.87 | 45.92 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 5.46 | 7.66 | 7.64 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Intimation of Earnings Call with Investors and Analysts on Tuesday, 27th October, 2026
Intimation of Earnings Call with Investors and Analysts on Tuesday, 27th October, 2026
Certificate Under Regulation 74(5) of SEBI( Depositories Participants) Regulations, 2015
Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Intimation of schedule ....
Intimation of Schedule of Institutional Investors/Analyst meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Intimation of Schedule of Institutional Investors and Analysts meeting to be held on Wednesday, 19th August, 2026
Compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015.
Unaudited Financial Results of the Company for the Quarter ended 30th June, 2026.
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2025 - Resignation of Mr. Ninad D. Gupte as Non-Executive, Non-Independent Director of the Company.
Integrated Filing (Financial) for the quarter ended 30th June, 2026.
Proceedings of 26th Annual General Meeting.
Certificate under regulation 74(5) of SEBI(Depositories Participants) Regulations, 2015
Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Intimation of Schedule ....
Notice Of 26TH Annual General Meeting Of The Company To Be Held On 27TH July, 2026.
Annual Report for F.Y. 2025-26.
Notice of 26Th Annual General Meeting Of The Company To Be Held On 27TH July, 2026.
Annual Report for F.Y. 2025-26.
Annual Report for F.Y. 2025-26.
Business Responsibility and Sustainability Report 2025-26
Notice of 26th Annual General Meeting of the Company to be held on 27th July, 2026.
Record date for ascertaining eligibility of shareholders for payment of Dividend for F.Y. 2025-26.
Integrated Filing (Financial) for the quarter and year ended 31st March, 2026.
Recording of the Earning Call held on 28th May, 2026
Investor Presentation for the quarter and year ended 31st March, 2026
Audited Financial Results of the Company for the Year ended 31st March, 2026 and Final Dividend Recommendation.
Promotion of Dr Suresh Ramachandran as Managing Director of the Company with effect from 1st September, 2026.
Disclosure about Appointment/Reappointment of Independent Directors and Appointment of Non Executive Director.
Annual Secretarial Compliance Report for the year ended 31st March, 2026.
Intimation of Earnings Call with Investors and Analysts on Thursday, 28th May, 2026
Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Intimation of schedule ....
Intimation of Credit rating
Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Change in Management Personnel.
Intimation of Schedule of Institutional Investors/Analyst meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Revised Investor Presentation - Quarter and Nine Months Ended 31st December, 2025.
Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2025.
Investor Presentation on Financial Results of the Company for the quarter and nine months ended 31st December, 2025.
Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2025.
Certificate under Regulations 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 2025.
Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2026 ,inter alia, to consider and approve Intimation of schedule ....
Report on violation to Code of Conduct under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
Written Transcript of Earnings Call held on 28th October, 2025.
Audio Recording of Earnings Call held on 28th October, 2025.
Integrated Filing (Financial) for the quarter and half-year ended 30th September, 2025.
Investor Presentation on Financial Results for the quarter and half year ended 30th September, 2025
Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended 30th September, 2025.
Intimation of Earnings Call with Investors and Analysts on Tuesday, 28th October, 2025
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2025.
Sumitomo Chemical India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 ,inter alia, to consider and approve UNAUDITED FINANCIAL ....
Intimation regarding "Saksham Niveshak", a 100 days campaign under the notification of Investor Education and Protection Fund Authority(IEPFA), Ministry of Corporate Affairs (MCA).
Annual Reports
7Credit Ratings
6Concalls
27Jan 2026
31 Jan 2026Jan 2026
31 Jan 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025Jan 2025
31 Jan 2025Nov 2024
30 Nov 2024Jul 2024
31 Jul 2024Jun 2024
30 Jun 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Held by ETFs
15 ETFs hold SUMICHEM · sorted by weight
Held by Mutual Funds
51 schemes hold SUMICHEM · sorted by weight